These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 18078869)

  • 21. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
    Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
    Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report.
    Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A
    Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
    Alford FP; Hew FL; Christopher MC; Rantzau C
    J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
    Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
    Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
    Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone therapy in GH-deficient adults: continuous vs alternate-days treatment.
    Giavoli C; Cappiello V; Porretti S; Ronchi CL; Orsi E; Beck-Peccoz P; Arosio M
    Horm Metab Res; 2003 Sep; 35(9):557-61. PubMed ID: 14517774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
    Jørgensen JO; Nørrelund H; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1355-60. PubMed ID: 12510991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
    Attallah H; Friedlander AL; Hoffman AR
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.
    Trepp R; Stettler C; Diem P; Christ ER
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference.
    Soares DV; Conceição FL; Brasil RR; Spina LD; Lobo PM; Silva EM; Buescu A; Vaisman M
    Growth Horm IGF Res; 2004 Dec; 14(6):436-41. PubMed ID: 15519251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement.
    Colao A; Di Somma C; Rota F; Di Maio S; Salerno M; Klain A; Spiezia S; Lombardi G
    J Clin Endocrinol Metab; 2005 May; 90(5):2659-65. PubMed ID: 15713715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.